+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Electronic Drug Delivery System Market - Global Forecast 2026-2032- Product Image
Electronic Drug Delivery System Market - Global Forecast 2026-2032- Product Image
Sale

Electronic Drug Delivery System Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4896642
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Electronic Drug Delivery System Market is projected to reach USD 15.67 Billion in 2026. It is expected to continue growing at a CAGR of 12.92%, reaching USD 32.85 Billion by 2032.

Electronic drug delivery systems are moving from stand-alone administration devices to connected therapeutic platforms that improve medication adherence, dose accuracy, and clinical visibility. The category includes smart injection pens, electronic autoinjectors, wearable injectors, connected inhalers, programmable infusion pumps, and digitally enabled transdermal or implantable systems used across diabetes, respiratory disease, oncology, autoimmune conditions, pain management, and hospital care.

Demand is supported by durable clinical realities: the World Health Organization identifies noncommunicable diseases as the leading cause of death worldwide, the International Diabetes Federation reports hundreds of millions of adults living with diabetes, and aging populations are increasing the need for home-based treatment. For manufacturers, payers, and providers, the opportunity extends beyond device shipments to the creation of secure data ecosystems around dosing, monitoring, reminders, adherence support, and therapy optimization.

Transformative Shifts in the Electronic Drug Delivery Landscape

The electronic drug delivery system landscape is being reshaped by the convergence of medical devices, digital therapeutics, remote patient monitoring, and specialty pharmaceuticals. Biologics and high-value injectables have increased interest in wearable injectors and electronic autoinjectors that can handle larger volumes, support self-administration, and document use outside clinical settings.

Regulatory modernization is another decisive shift. The U.S. FDA’s guidance on combination products, human factors engineering, cybersecurity, and software as a medical device has raised expectations for safety evidence and lifecycle management. In Europe, the Medical Device Regulation has intensified clinical evaluation, post-market surveillance, and technical documentation requirements, making regulatory readiness a competitive differentiator.

Commercial models are also changing. Hospitals are prioritizing smart infusion safety, pharmaceutical sponsors are pairing therapies with connected delivery tools, and payers are looking for adherence evidence that can reduce avoidable complications. As a result, device developers increasingly compete on interoperability, usability, cybersecurity, supply reliability, and real-world evidence generation.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence electronic drug delivery systems through dose-support analytics, anomaly detection, predictive maintenance, patient engagement, and population-level adherence insights. In diabetes care, algorithm-assisted insulin delivery has already demonstrated how sensor data, dosing history, and software can help reduce manual burden while supporting tighter therapy management under clinician oversight.

AI also strengthens operational performance. Manufacturers can use machine learning for quality control, component traceability, complaint analysis, and risk monitoring, while healthcare organizations can apply predictive models to identify patients at risk of missed doses or device misuse. These applications align with the FDA’s growing review experience in AI-enabled medical software and the broader industry shift toward evidence-based digital health.

The cumulative impact is significant but must remain governed. AI-enabled delivery platforms require transparent validation, bias assessment, cybersecurity controls, human factors testing, and post-market monitoring. Companies that treat AI as a regulated clinical capability rather than a marketing feature will be better positioned to earn trust from regulators, clinicians, and patients.

Key Regional Insights

Asia-Pacific is becoming a high-priority growth arena because of large diabetes and respiratory disease populations, expanding health insurance coverage, and rapid adoption of mobile health across China, India, Japan, South Korea, Australia, and ASEAN markets. North America remains a technology leader, supported by advanced reimbursement structures, high specialty drug use, mature diabetes device adoption, remote patient monitoring infrastructure, and a robust FDA pathway for combination products and connected medical devices.

Europe benefits from strong public health systems, established medtech manufacturing, and rigorous post-market requirements under the MDR, which favor vendors with strong clinical evidence, quality systems, and data protection capabilities. Latin America is gaining relevance as Brazil and Mexico expand chronic disease management programs, although affordability, import dependence, public-private reimbursement variation, and uneven digital infrastructure continue to shape adoption.

The Middle East is investing in digital hospitals, diabetes care, and local healthcare capacity, particularly in GCC countries with national transformation programs and high demand for connected chronic care solutions. Africa remains earlier in adoption but strategically important due to rising noncommunicable disease burden, urbanization, and opportunities for durable, low-maintenance, mobile-connected drug delivery solutions suited to decentralized care and resource-constrained settings.

Key Group Insights

ASEAN markets are increasingly attractive for connected inhalers, insulin delivery, and home-care injection devices because urban health systems are expanding and governments are investing in universal health coverage and digital health infrastructure. The GCC is distinguished by high diabetes prevalence, strong hospital modernization, and national digital health strategies that support connected care adoption when data residency, interoperability, and procurement requirements are addressed.

The European Union is a critical regulatory and commercial benchmark because MDR compliance, GDPR data protection, and health technology assessment expectations influence global product design and evidence generation. BRICS economies combine large patient populations with rising domestic manufacturing capacity, making localization, pricing flexibility, clinical partnerships, and resilient supply chains essential for electronic drug delivery system adoption.

G7 countries represent the most mature demand base for premium electronic drug delivery systems due to established specialty pharmaceutical utilization, advanced clinical infrastructure, aging populations, and higher digital health readiness. NATO countries, while not a healthcare bloc, overlap with many advanced procurement, cybersecurity, and supply resilience jurisdictions, increasing the importance of secure software architectures, traceable components, and continuity planning.

Key Country Insights

The United States leads adoption through strong specialty drug utilization, diabetes technology use, home infusion growth, remote care infrastructure, and FDA-regulated innovation. Canada favors clinically validated devices aligned with public payer priorities and chronic disease management goals, while Mexico’s opportunity is linked to chronic disease burden, private-sector healthcare growth, and improving access to connected care. Brazil is Latin America’s largest healthcare market, with demand supported by diabetes care needs, hospital modernization, and broader digital health initiatives.

In Europe, the United Kingdom emphasizes NHS efficiency, remote monitoring, and evidence-based procurement. Germany and France remain major medtech markets with strong reimbursement scrutiny and high expectations for clinical documentation, while Italy and Spain offer demand through aging populations and chronic disease management programs. Russia’s market is influenced by localization policy, procurement constraints, and access challenges that affect advanced device availability.

China and India are central to long-term adoption because of large patient populations, rising chronic disease prevalence, expanding insurance coverage, and growing domestic medtech capabilities. Japan, South Korea, and Australia favor high-quality, connected, and user-friendly devices supported by advanced clinical systems, aging demographics, strong regulatory oversight, and increasing acceptance of home-based care models.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize patient-centered device design, validated connectivity, and end-to-end cybersecurity from concept through post-market support. Human factors engineering is essential because self-administration devices must work reliably for older adults, patients with dexterity limitations, caregivers, and users with variable digital literacy.

Companies should build evidence packages that combine clinical performance, adherence outcomes, health economic value, and real-world data. Partnerships with pharmaceutical sponsors, cloud infrastructure providers, payers, and care delivery organizations can accelerate scale, but governance over data ownership, privacy, interoperability, cybersecurity responsibilities, and software updates must be explicit.

To improve resilience, leaders should diversify critical component sourcing, invest in automated quality systems, and design platforms that can be localized for regional regulatory, language, reimbursement, and connectivity requirements. The strongest market positions will come from integrated platforms that combine reliable drug delivery with measurable clinical and economic value.

Research Methodology

This executive summary is developed from a structured secondary research approach using publicly available regulatory guidance, health agency data, clinical literature, government publications, and recognized industry sources. Key reference points include the U.S. FDA, European Commission, WHO, OECD, World Bank, International Diabetes Federation, national health agencies, and peer-reviewed publications on connected drug delivery, chronic disease management, medication adherence, cybersecurity, and digital health regulation.

The analysis evaluates demand drivers, regulatory dynamics, technology adoption, regional healthcare infrastructure, and competitive implications across electronic injectors, connected inhalers, infusion systems, wearable injectors, and related software-enabled platforms. Insights are synthesized to support strategic decision-making without relying on unverified market claims, unsupported projections, market sizing, market share estimates, or forecasting.

Conclusion

Electronic drug delivery systems are becoming essential infrastructure for precision, connected, and patient-centered care. Their value is strongest where chronic disease burden, specialty medicine utilization, home-based treatment, and digital health readiness intersect.

The next phase of competition will depend on evidence, interoperability, cybersecurity, usability, regulatory execution, and real-world outcomes. Organizations that integrate device reliability with actionable data and measurable clinical value will be best positioned to lead this evolving electronic drug delivery system landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Electronic Drug Delivery System Market, by Device Type
7.1. Introduction
7.2. Injectable Devices
7.2.1. Electronic Auto Injectors
7.2.2. Smart Jet Injectors
7.3. Electronic Inhalation Devices
7.3.1. Smart Dry Powder Inhalers
7.3.2. Smart Metered Dose Inhalers
7.3.3. Smart Soft Mist Inhalers
7.4. Electronic Infusion Pumps
7.4.1. Insulin Pumps
7.4.2. Infusion Pumps
7.5. Oral Systems
8. Electronic Drug Delivery System Market, by Route Of Administration
8.1. Introduction
8.2. Inhalation
8.3. Injection
8.4. Intranasal
8.5. Intrathecal
8.6. Ophthalmic
8.7. Transdermal
9. Electronic Drug Delivery System Market, by Therapeutic Area
9.1. Introduction
9.2. Diabetes
9.3. Oncology
9.4. Cardiovascular Diseases
9.5. Neurological Disorders
9.6. Autoimmune Diseases
10. Electronic Drug Delivery System Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Hospital Pharmacies
10.4. Online Pharmacies
10.5. Retail Pharmacies
11. Electronic Drug Delivery System Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Home Healthcare
11.4. Hospitals & Clinics
11.5. Specialty Clinics
12. Electronic Drug Delivery System Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Electronic Drug Delivery System Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Electronic Drug Delivery System Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AptarGroup, Inc.
16.2. AstraZeneca plc
16.3. B. Braun Melsungen AG
16.4. Baxter International Inc.
16.5. Becton, Dickinson and Company
16.6. Debiotech SA
16.7. F. Hoffmann-La Roche Ltd.
16.8. Flowonix Medical, Inc.
16.9. Gerresheimer AG
16.10. Haselmeier GmbH
16.11. ICU Medical, Inc.
16.12. Insulet Corporation
16.13. Medtronic plc
16.14. Merck KGaA
16.15. Molex LLC
16.16. Nemera
16.17. Novo Nordisk A/S
16.18. Owen Mumford Ltd.
16.19. SHL Medical AG
16.20. Smiths Group plc
16.21. Stevanato Group
16.22. Tandem Diabetes Care, Inc.
16.23. Terumo Corporation
16.24. Teva Pharmaceuticals
16.25. West Pharmaceutical Services, Inc.
16.26. Ypsomed AG
List of Figures
FIGURE 1. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INJECTABLE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INJECTABLE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INJECTABLE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ELECTRONIC AUTO INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ELECTRONIC AUTO INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ELECTRONIC AUTO INJECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SMART JET INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SMART JET INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SMART JET INJECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL ELECTRONIC INHALATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL ELECTRONIC INHALATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL ELECTRONIC INHALATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SMART DRY POWDER INHALERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SMART DRY POWDER INHALERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SMART DRY POWDER INHALERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SMART METERED DOSE INHALERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SMART METERED DOSE INHALERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SMART METERED DOSE INHALERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SMART SOFT MIST INHALERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SMART SOFT MIST INHALERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SMART SOFT MIST INHALERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL ELECTRONIC INFUSION PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ELECTRONIC INFUSION PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ELECTRONIC INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL INFUSION PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL INFUSION PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ORAL SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ORAL SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ORAL SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL INHALATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL INHALATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL INHALATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL INJECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL INJECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL INJECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL INTRANASAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL INTRANASAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL INTRANASAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL INTRATHECAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL INTRATHECAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL INTRATHECAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL OPHTHALMIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL OPHTHALMIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL OPHTHALMIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL TRANSDERMAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL TRANSDERMAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL TRANSDERMAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL HOME HEALTHCARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL HOME HEALTHCARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 111. NORTH AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 112. NORTH AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. LATIN AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. LATIN AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 119. LATIN AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 120. LATIN AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 121. LATIN AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 122. LATIN AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 123. LATIN AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. EUROPE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. EUROPE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 128. EUROPE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 129. EUROPE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 130. EUROPE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 131. EUROPE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 132. EUROPE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 133. EUROPE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 134. EUROPE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 135. MIDDLE EAST ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. MIDDLE EAST ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 137. MIDDLE EAST ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 138. MIDDLE EAST ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 139. MIDDLE EAST ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 140. MIDDLE EAST ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 141. MIDDLE EAST ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 142. MIDDLE EAST ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 143. MIDDLE EAST ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 144. AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 146. AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 147. AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 148. AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 149. AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 150. AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 151. AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 152. AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 154. ASEAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 155. ASEAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 156. ASEAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 157. ASEAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 158. ASEAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 159. ASEAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 160. ASEAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 161. ASEAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 162. ASEAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 163. GCC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. GCC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 165. GCC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 166. GCC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 167. GCC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 168. GCC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 169. GCC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 170. GCC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 171. GCC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 181. BRICS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. BRICS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 183. BRICS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 184. BRICS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 185. BRICS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 186. BRICS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 187. BRICS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 188. BRICS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 189. BRICS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. G7 ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 191. G7 ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 192. G7 ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 193. G7 ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 194. G7 ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 195. G7 ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 196. G7 ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 197. G7 ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 198. G7 ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 199. NATO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 200. NATO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 201. NATO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 202. NATO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 203. NATO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 204. NATO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 205. NATO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 206. NATO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 207. NATO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 208. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 209. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 210. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 211. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 212. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 213. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 214. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 215. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 216. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 217. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 219. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 220. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 221. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 222. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 223. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 224. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 225. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 226. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 228. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 229. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 230. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 231. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 232. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 233. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 234. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 235. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 236. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 237. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 238. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 239. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 240. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 241. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 242. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 243. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 244. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 247. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 248. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 249. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 250. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 251. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 252. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 253. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 256. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 257. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 258. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 259. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 260. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 261. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 262. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 265. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 266. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 267. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 268. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 269. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 270. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 271. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 272. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 274. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 275. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 276. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 277. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 278. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 279. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 280. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 281. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 282. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 283. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 284. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 285. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 286. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 287. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 288. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 289. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 290. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 292. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 293. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 294. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 295. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 296. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 297. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 298. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 299. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 301. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 302. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 303. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 304. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 305. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 306. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 307. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 309. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 310. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 311. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 312. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 313. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 314. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 315. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 316. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 317. JAPAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 318. JAPAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 319. JAPAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 320. JAPAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALATION DEVICES, 2017-2032 (USD MILLION)
TABLE 321. JAPAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INFUSION PUMPS, 2017-

Companies Mentioned

  • AptarGroup, Inc.
  • AstraZeneca plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Debiotech SA
  • F. Hoffmann-La Roche Ltd.
  • Flowonix Medical, Inc.
  • Gerresheimer AG
  • Haselmeier GmbH
  • ICU Medical, Inc.
  • Insulet Corporation
  • Medtronic plc
  • Merck KGaA
  • Molex LLC
  • Nemera
  • Novo Nordisk A/S
  • Owen Mumford Ltd.
  • SHL Medical AG
  • Smiths Group plc
  • Stevanato Group
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Teva Pharmaceuticals
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 15.67 Billion
Forecasted Market Value ( USD ) by 2032 $ 32.85 Billion
Compound Annual Growth Rate12.9%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Novel Drug Delivery Systems Market - Global Forecast 2026-2032 - Product Image

Novel Drug Delivery Systems Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Targeted Drug Delivery System Market - Global Forecast 2026-2032 - Product Image

Targeted Drug Delivery System Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Electronic Drug Delivery Systems - Global Strategic Business Report - Product Image

Electronic Drug Delivery Systems - Global Strategic Business Report

  • Report
  • 288 Pages
  • Global
From
Electronic Drug Delivery Systems Market Report 2026 - Product Image

Electronic Drug Delivery Systems Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Smart Drug Delivery Systems Market Report 2026 - Product Image

Smart Drug Delivery Systems Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Electronic Drug Delivery System Market

The Electronic Drug Delivery System (EDDS) market is a subset of the larger drug delivery market. EDDS is a technology-driven system that enables the delivery of drugs to patients in a safe and efficient manner. It is used to monitor and control the delivery of drugs, as well as to provide real-time data on drug usage. EDDS can be used to deliver drugs to patients in a variety of settings, including hospitals, clinics, and home care. EDDS can be used to improve patient safety and reduce the risk of medication errors. It can also help to reduce the cost of drug delivery, as well as improve the accuracy and speed of drug delivery. EDDS can also be used to monitor drug usage and provide real-time data on drug usage. Some companies in the EDDS market include Becton Dickinson, Baxter International, and Novo Nordisk. Other companies include Merck, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.